Exact Mass: 529.2173
Exact Mass Matches: 529.2173
Found 101 metabolites which its exact mass value is equals to given mass value 529.2173
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Kapporphin
Derived from the kappa-chain of immunoglobulin
Ala Asn Tyr Tyr
Ala Tyr Asn Tyr
Ala Tyr Tyr Asn
Phe Asn Ser Tyr
Phe Asn Tyr Ser
Phe Ser Asn Tyr
Phe Ser Tyr Asn
Phe Tyr Asn Ser
Phe Tyr Ser Asn
Gly His Met Trp
Gly His Trp Met
Gly Met His Trp
Gly Met Trp His
Gly Gln Tyr Tyr
Gly Trp His Met
Gly Trp Met His
Gly Tyr Gln Tyr
Gly Tyr Tyr Gln
His Gly Met Trp
His Gly Trp Met
His Met Gly Trp
His Met Trp Gly
His Trp Gly Met
His Trp Met Gly
Met Gly His Trp
Met Gly Trp His
Met His Gly Trp
Met His Trp Gly
Met Trp Gly His
Met Trp His Gly
Asn Ala Tyr Tyr
Asn Phe Ser Tyr
Asn Phe Tyr Ser
Asn Ser Phe Tyr
Asn Ser Tyr Phe
Asn Tyr Ala Tyr
Asn Tyr Phe Ser
Asn Tyr Ser Phe
Asn Tyr Tyr Ala
Gln Gly Tyr Tyr
Gln Tyr Gly Tyr
Gln Tyr Tyr Gly
Ser Phe Asn Tyr
Ser Phe Tyr Asn
Ser Asn Phe Tyr
Ser Asn Tyr Phe
Ser Tyr Phe Asn
Ser Tyr Asn Phe
Trp Gly His Met
Trp Gly Met His
Trp His Gly Met
Trp His Met Gly
Trp Met Gly His
Trp Met His Gly
Tyr Ala Asn Tyr
Tyr Ala Tyr Asn
Tyr Phe Asn Ser
Tyr Phe Ser Asn
Tyr Gly Gln Tyr
Tyr Gly Tyr Gln
Tyr Asn Ala Tyr
Tyr Asn Phe Ser
Tyr Asn Ser Phe
Tyr Asn Tyr Ala
Tyr Gln Gly Tyr
Tyr Gln Tyr Gly
Tyr Ser Phe Asn
Tyr Ser Asn Phe
Tyr Tyr Ala Asn
Tyr Tyr Gly Gln
Tyr Tyr Asn Ala
Tyr Tyr Gln Gly
7-[2-(diethylamino)ethyl]-1,3-dimethylpurine-2,6-dione,2-(7-hydroxy-4-methyl-2-oxochromen-6-yl)oxyacetic acid
(+)-(3r,4r)-bis(diphenylphosphino)-1-benzylpyrrolidine
ezatiostat
C471 - Enzyme Inhibitor > C2137 - Glutathione Transferase Inhibitor Ezatiostat (TER199 free base; TLK199) is a tripeptide analog of glutathione and is a selective and orally active glutathione S-transferase P1-1 (GSTP1) inhibitor. Ezatiostat leads to JNK activation by inhibiting GSTP1. Ezatiostat stimulates both lymphocyte production and bone marrow progenitor proliferation. Ezatiostat has the potential for myelodysplastic syndrome (MDS) treatment[1][2].
2-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[(1R,2R)-2-methoxy-1-[[(2S)-1-methylpyrrolidin-1-ium-2-carbonyl]amino]propyl]oxan-2-yl]sulfanylethyl 2-hydroxybenzoate
NSC 23766 trihydrochloride
NSC 23766 trihydrochloride is an inhibitor of Rac1 activation.